SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-21-011754
Filing Date
2021-05-12
Accepted
2021-05-12 07:30:10
Documents
4
Period of Report
2021-05-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dffn20210511_8k.htm 8-K 28082
2 EXHIBIT 99.1 ex_248974.htm EX-99.1 19791
3 EXHIBIT 99.2 ex_248975.htm EX-99.2 19334
4 logo.jpg GRAPHIC 6909
  Complete submission text file 0001437749-21-011754.txt   78300
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37942 | Film No.: 21913450
SIC: 2834 Pharmaceutical Preparations